Takashi Nagayama

7PUBLICATIONS
32CO-AUTHORS
HaematologyTransplantation immunologyAutoimmunityRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 27, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.

|Jan 14, 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.

Shunto Kawamura, Daishi Nakagawa, Takashi Nagayama

|Apr 06, 2024
Effects of CD34+ cell dose on engraftment and long-term outcomes after allogeneic bone marrow transplantation.

Takashi Oyama, Shin-Ichiro Fujiwara, Ryutaro Tominaga

|Aug 29, 2023
Early reversal of the lymphocyte-to-monocyte ratio after allogeneic-hematopoietic stem cell transplantation is associated with reduced relapse and improved prognosis.

Takashi Nagayama, Shin-Ichiro Fujiwara, Ryutaro Tominaga

|Jun 26, 2023
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect.

Kento Umino, Kaoru Morita, Takashi Ikeda

|May 17, 2022
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.

Chihiro Yamamoto, Daisuke Minakata, Shunsuke Koyama

Pageof 2

Frequent Collaborators

3 joint publications

Noriko Doki

3 joint publications

Junya Kanda

3 joint publications

Hideki Nakasone

2 joint publications

Chihiro Yamamoto